 |
2009 ASCO Annual Meeting― Orlando, FL |
|
2009 Kyoto Breast Cancer Consensus Conference International Convention―Kyoto, Japan |
|
2009 United States and Canadian Academy of Pathology (USCAP) Annual Meeting Boston, MA |
|
2008 San Antonio Breast Cancer Symposium (SABCS)-San Antonio, TX |
|
2008 Hematology/Oncology Pharmacy Association (HOPA)—Anaheim, CA |
|
2008 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium—Washington DC |
|
2008 ASCO Annual Meeting―Chicago, IL |
|
2008 United States and Canadian Academy of Pathology (USCAP) Annual Meeting―Denver, CO |
|
2008 ASCO Gastrointestinal Cancers Symposium—Orlando, FL |
|
2007 San Antonio Breast Cancer Symposium (SABCS)―San Antonio, TX |
|
2007 ASCO Breast Cancer Symposium―San Francisco, CA |
|
2007 ASCO Annual Meeting―Chicago, IL |
|
2007 American Association for Cancer Research (AACR) Annual Meeting―Los Angeles, CA |
|
2006 Association for Molecular Pathology (AMP) Annual Meeting―Orlando, FL |
|
2006 SABCS―San Antonio, TX |
|
2006 ASCO Annual Meeting―Atlanta, GA |
|
2006 AACR Annual Meeting―Washington, DC |
|
2005 SABCS―San Antonio, TX |
|
2005 ASCO Annual Meeting―Orlando, FL |
|
2004 SABCS―San Antonio, TX |
|
2004 ASCO Annual Meeting―New Orleans, LA |
|
2004 USCAP Annual Meeting―Vancouver, British Columbia |
|
2003 SABCS―San Antonio, TX |
|
2003 ASCO Annual Meeting―Chicago, IL |
|
2003 AACR Oncogenomics Meeting―Phoenix, AZ |
|
EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
|
2002 ASCO Annual Meeting―Orlando, FL |
|
| |
|
|
2009 ASCO Annual Meeting― Orlando, FL |
| Abstract # 500 |
| Genotypic characterization of phenotypically defined triple-negative breast cancer |
| J. A. Sparano, L. J. Goldestin, B. H. Childs, S. Shak, S. Badve, F. L. Baehner |
| |
| |
|
| Abstract # 549 |
| Molecular characterization of male breast cancer by standardized quantitative RTPCR analysis: First large genomic study of 347 male breast cancers compared to 82,434 female breast cancers. |
| S. Shak, G. Palmer, F. L. Baehner, C. Millward, D. Watson, G. W. Sledge |
| |
| |
2009 Kyoto Breast Cancer Consensus Conference International Convention Kyoto, Japan |
| Abstract |
| The First Report Of The Association Between The Recurrence Score And The Risk Of Recurrence In A Japanese Population |
| M. Toi, H. Iwata, N. Masuda, S. Ohno, S. Namakura, Y.Yamanaka, T. Nakayama, M. Kashiwaba, S, Kamigaki, K. Aogi, T. Ueno, K. Kuroi. |
| |
| |
2009 United States and Canadian Academy of Pathology (USCAP) Annual Meeting Boston, MA |
| Abstract # 1421 |
| HER2 Concordance between Central Laboratory Immunohistochemistry, FISH and Quantitative RT-PCR in Intergroup Trial E2197 |
| Baehner FL, Gray R, Maddala T, Childs B, Rowley S, Shak S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA, Badve S |
| |
| |
|
| Abstract # 1574 |
| Biopsy Cavities in Breast Cancer Specimens: Impact on Quantitative RT-PCR Gene Expression Profiles and Recurrence Risk Assessment |
| FL Baehner, C Quale, C Pomeroy, D Cherbavaz, S Shak. |
| |
| |
|
| Abstract # 2285 |
| ER and PR Assessment by Central IHC: Examination and Comparison of Percent Positive Cells and Nuclear Staining Intensity in ECOG Breast Cancer Study 2197 |
| S Badve, R Gray, B Childs, T Maddala, M Liu, S Rowley, N Davidson, S Shak, LJ Goldstein, GW Sledge, JA Sparano, FL Baehner |
| |
| |
2008 San Antonio Breast Cancer Symposium (SABCS)-San Antonio, TX |
| Abstract # 25 |
| GRB7-dependent pathways are potential therapeutic targets in triple-negative breast cancer. |
| Sparano JA, Gray R, Goldstein LJ, Childs BH, Bugarini R, Rowley S, Baker J, Shak S, Badve S, Baehner FL, Perez EA, Shulman LN, Martino S, Sledge Jr. GW, Davidson |
| |
| |
|
| Abstract # 53 |
| Risk of distant recurrence using oncotype DX in postmenopausal primary breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study |
| Dowsett M, Cuzick J, Wales C, Forbes J, Mallon L, Salter J, Quinn E, Bugarini R, Baehner FL, Shak S, on Behalf of the ATAC Trialists' Group Royal Marsden Hospital, London, United Kingdom; Wolfson Institute for Preventive Medicine, London, United Kingdom; Newcastle Mater Hospital, Newcastle, Australia; Royal Infirmary, Glasgow,United Kingdom; Genomic Health Institute, Redwood, CA |
| |
| |
|
| Abstract # 2066 |
| Quantitative gene expression analysis using Oncotype DX in ductal carcinoma in situ that is adjacent to invasive ductal carcinoma. |
| Baehner FL, Sangli C, Millward C, Cherbavaz D, Goddard A, Shak S Genomic Health, Inc, Redwood City, CA |
| |
| |
|
| Abstract # 3049 |
| Associations between estrogen receptor (ER) Alpha expression levels and ER genotypes |
| Henry NL, Shak S, Banerjee M, Skaar T, Palmer G, Braman M, Stearns V, Flockhart DA, Kleer C, Hayes DF, Rae J University of Michigan, Ann Arbor, MI; Genomic Health,Inc., Redwood City, CA; Indiana University, Indianapolis, IN; Johns Hopkins University,Baltimore, MD |
| |
| |
2008 Hematology/Oncology Pharmacy Association (HOPA)—Anaheim, CA |
| Abstract # 2601: Poster Session |
| Low Recurrence Score by the Oncotype DX Breast Cancer Assay Rarely Results in Recommendation for or Administration of Chemotherapy: A Pooled Analysis |
| P Hall, S Skrypczak, G Palmer |
| |
| |
2008 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium—Washington DC |
| Abstract #13 |
| HER2 Concordance Between Central Laboratory Immunohistochemistry & Quantitative Reverse Transcription Polymerase Chain Reaction in Intergroup Trial E2197 |
| FL Baehner, R Gray, B Childs, T Maddala, S Rowley, S Shak, NE Davidson, GW Sledge, LJ Goldstein, JA Sparano, S Badve |
| |
| |
|
| Abstract #41 |
| HER2 Assessment in a Large Kaiser Permanente Case-Control Study: Comparison of Fluorescence In Situ Hybridization (FISH) and Quantitative Reverse Transcription Polymerase Chain Reaction (RTPCR) Performed by Central Laboratories |
| FL Baehner, Achacoso, T Maddala, C Alexander, S Shak, CP Quesenberry, LC Goldstein, AM Gown, LA Habel |
| |
| |
2008 ASCO Annual Meeting—Chicago, IL |
| Abstract #3512 |
| Evaluation of Tumor Gene Expression and K-Ras Mutations in FFPE Tumor Tissue as Predictors of Response to Cetuximab in Metastatic Colorectal Cancer |
| JB Baker, D Dutta, D Watson, T Maddala, S Shak, EK Rowinsky, L Xu, E Clark, DJ Mauro, S Khambata-Ford |
| |
| |
|
| Abstract #557 |
| Predictive Utility of Progesterone Receptor (PR) and Multigene Expression in Identifying Benefit From Adjuvant Doxorubicin Plus Cyclophosphamide (AC) or Docetaxel (AT) in Intergroup Trial E2197. |
| LJ Goldstein, RJ Gray, R Bugarini, S Shak, SS Badve, FL Baehner, NE Davidson, GW Sledge, JA Sparano, The North American Breast Cancer Intergroup |
| |
| |
2008 United States and Canadian Academy of Pathology (USCAP) Annual Meeting—Denver, CO |
| Abstract #82: Oral Presentation |
| Analysis of Revised Nottingham Tumor Grade Constitutive Components and Recurrence Free Interval in ECOG Breast Cancer Study E2197 |
| FL Baehner, LJ Goldstein, R Gray, T Maddala, S Shak, GW Sledge, JA Sparano, S Badve |
| |
| |
|
| Abstract #44: Poster Session |
| Comparison of ER and PR Assessment by Local IHC, Central IHC, and Central Quantitative RT-PCR in ECOG Breast Cancer Study 2197 |
| S Badve, FL Baehner, R Gray, B Childs, T Maddala, M Liu, S Rowley, N Davidson, LJ Goldstein, GW Sledge, JA Sparano |
| |
| |
|
| Abstract #47: Poster Session |
| A Kaiser-Permanente Population-Based Study of Breast Cancer ER and PR Expression by the Standard Method, Immunohistochemistry, Compared to a New Method, Quantitative Reverse Transcription Polymerase Chain Reaction |
| FL Baehner, T Maddala, C Alexander, A Gown, LC Goldstein, y, S Shak, CP Quesenberry, L Habel |
| |
| |
|
| Abstract #50: Poster Session |
| Heterogeneity of Quantitative RT-PCR Measurement of Estrogen and Progesterone Receptor Expression: Comparison of Tissue Microarray Cores to Whole Sections of Paraffin Embedded Breast Cancer Tissue |
| FL Baehner, J Baker, J Salter, ML Liu, C Yoshizawa, T Maddala, M Dowsett, M Cronin, S Shak |
| |
| |
2008 ASCO Gastrointestinal Cancers Symposium—Orlando, FL |
| Abstract #301: Poster Session |
| Relationship Between Tumor Gene Expression and Recurrence in Patients with Stage II/III Colon Cancer Treated with Surgery + 5-FU/LV in NSABP C-06: Consistency of Results with Two Other Independent Studies |
| MJ O'Connell, G Yothers, S Paik, IC Lavery, JW Cowens, KM Clark-Langone, MLopatin, JR Hackett, FL Baehner, N Wolmark |
| |
| |
|
| Abstract #302: Poster Session |
| Relationship Between Tumor Gene Expression and Recurrence in an Observational Cohort of Patients with Stage II/III Colon Cancer Treated with Surgery Only: Quantitative RT-PCR Assay of 375 Genes in Fixed Paraffin-Embedded (FPE) Tissue |
| I Lavery, J Hammel, J Cowens, K Clark-Langone, J Hackett, F Baehner,
G Yothers, M O'Connell, N Wolmark
|
| |
| |
2007 San Antonio Breast Cancer Symposium (SABCS)―San Antonio, TX |
| Abstract #10: Oral Presentation |
| Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in Postmenopausal, Node-Positive, ER-Positive Breast Cancer |
| K Albain, W Barlow, S Shak, G Hortobagyi, R Livingston, I Yeh, P Ravdin, C Yoshizawa, FL Baehner, N Davidson, G Sledge, E Winer, C Hudis, J Ingle, E Perez, K Pritchard, L Shepherd, C Allred, K Osborne, D Hayes |
| |
| |
|
| Abstract #63: Oral Presentation |
| Prognostic Utility of the 21-Gene Assay Compared with Adjuvant! in Hormone Receptor (HR) Positive Operable Breast Cancer with 0-3 Positive Axillary Nodes Treated with Adjuvant Chemohormonal Therapy (CHT): An Analysis of Intergroup Trial E2197 |
| L Goldstein, P Ravdin, R Gray, C Yoshizawa, B Childs, S Rowley, S Shak, S Badve, FL Baehner, N Davidson, GW Sledge, JA Sparano |
| |
| |
|
| Abstract #1043: Poster Session |
| Recurrence Score by Oncotype DX Evaluated on the Primary Breast Predicts the 2-Year Survival after First Relapse |
| G Bianchini, M Zambetti, P Mariani, A Moliterni, G Bianchi, G Mariani, A Fasolo, ML Carcangiu, P Valagussa, L Gianni |
| |
| |
|
| Abstract #1092: Poster Session |
| Prospective Multi-Center Study of the Impact of the 21-Gene Recurrence Score Assay on Patient Satisfaction, Anxiety and Decisional Conflict for Adjuvant Breast Cancer Treatment Selection |
| PB Mumby, SS Lo, J Norton, J Smerage, K Joseph, HK Chew, D Hayes, KS Albain |
| |
| |
|
| Abstract #2061: Poster Session |
| A Retrospective Analysis of the Impact of Oncotype DX Low Recurrence Score Results on Treatment Decisions in a Single Academic Breast Cancer Center |
| H Liang, AM Brufsky, BB Lembersky, P Rastogi, VG Vogel |
| |
| |
|
| Abstract #3028: Poster Session |
| Gene Expression by Standardized Quantitative RT-PCR in the Special Histologic Subtypes of Estrogen Receptor-Positive Invasive Breast Cancer |
| FL Baehner, D Watson, JT Ballard, G Palmer, S Shak |
| |
| |
|
| Abstract #3082: Poster Session |
| Evaluation of Practice Patterns in the Treatment of Node-Negative, Hormone-Receptor Positive Breast Cancer Patients with the Use of the Oncotype DX Assay at the University of Pennsylvania |
| C Erb, KR Fox, M Patel, K Hook, A DeMichele, C Kaplan, S Domchek |
| |
| |
|
| Abstract #5029: Poster Session |
| Estrogen Receptor and Breast Cancer Survival in a Kaiser Permanente Population-Based Study: Comparison of Quantitative Reverse Transcriptase Polymerase Chain Reaction and Immunohistochemistry |
| LA Habel, N Achacoso, T Maddala, C Alexander, FL Baehner, S Shak, C Quesenberry, AM Gown, LC Goldstein |
| |
| |
2007 ASCO Breast Cancer Symposium―San Francisco, CA |
| Abstract #27 |
| Association of Individual Genes with Risk of Relapse in Operable Breast Cancer: Analysis of E2197 |
| JA Sparano, L Goldstein, B Childs, C Yoshizawa, S Shak, J Baker, S Rowley, N Davidson, S Badve, GW Sledge Jr., R Gray |
| |
| |
|
| Abstract #87 |
| ER and PR Assessment in ECOG 2197: Comparison of Locally Determined IHC with Centrally Determined IHC and Quantitative RT-PCR |
| SS Badve, FL Baehner, R Gray, B Childs, T Maddala, M Liu, S Rowley, N Davidson, S Shak, GW Sledge Jr., JA Sparano |
| |
| |
|
| Abstract #88 |
| A Kaiser-Permanente Population-Based Study of ER and PR Expression by the Standard Method, Immunohistochemistry (IHC), Compared to a New Method, Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) |
| FL Baehner, T Maddala, C Alexander, A Gown, LC Goldstein, NS Achacoso, S Shak, CP Quesenberry, LA Habel |
| |
| |
|
| Abstract #106 |
| Use of Estrogen Receptor (ER) Expression by Quantitative RT-PCR to Identify an ER-Negative Subgroup by IHC Who Might Benefit from Hormonal Therapy |
| G Bianchini, M Zambetti, L Pusztai, M Carcangiu, P Valagussa, L Gianni |
| |
| |
2007 ASCO Annual Meeting―Chicago, IL |
| Abstract #526: Poster Discussion |
| Prognostic Utility of the 21-Gene Assay in Hormone Receptor (HR)-Positive Operable Breast Cancer and 0-3 Positive Axillary Nodes Treated with Adjuvant Chemohormonal Therapy (CHT): An Analysis of Intergroup Trial E2197 |
| LJ Goldstein, R Gray, B Childs, D Watson, S Rowley, S Shak, S Badve, NE Davidson, GW Sledge, JA Sparano |
| |
| |
|
| Abstract #577: Poster Session |
| Prospective Multi-Center Study of the Impact of the 21-Gene Recurrence Score (RS) Assay on Medical Oncologist (MO) and Patient (PT) Adjuvant Breast Cancer (BC) Treatment Selection |
| SS Lo, J Norton, PB Mumby, J Smerage, J Kash, HK Chew, D Hayes, A Epstein, KS Albain |
| |
| |
2007 American Association for Cancer Research (AACR) Annual Meeting―Los Angeles, CA |
| Abstract #4423: Poster Session |
| Optimized RNA Extraction and RT-PCR Provide Successful Molecular Analysis on a Variety of Archival Fixed Tissues |
| M Zhou, M Bronner, C Magi-Galluzzi, R Tuthill, FL Baehner, ML Liu, D Dutta, J Jeong, YT Chen, JR Hackett, M Cronin |
| |
| |
2006 Association for Molecular Pathology (AMP) Annual Meeting―Orlando, FL |
| Poster ST23 |
| Analytical Validation for the Oncotype DX Breast Cancer Assay, High Complexity, Multi-Analyte Molecular Diagnostic Test Service |
| M Cronin, C Sangli, ML Liu, M Pho, D Dutta, A Nguyen, J Jeong, J Wu, K Clark, D Watson |
| |
| |
2006 SABCS―San Antonio, TX |
| Abstract #45: Oral Presentation |
| Quantitative RT-PCR Analysis of ER and PR by Oncotype DX Indicates Distinct and Different Associations with Prognosis and Prediction of Tamoxifen Benefit |
| FL Baehner, LA Habel, CP Quesenberry, A Capra, G Tang, S Paik, N Wolmark, D Watson, S Shak |
| |
| |
|
| Abstract #3116: Poster Presentation |
| A Comparison of Estrogen Receptor (ER) Measurement by Three Methods in Node-Negative, Estrogen Receptor (ER)-Positive Breast Cancer: Ligand Binding (LB), Immunohistochemistry (IHC), and Quantitative RT-PCR |
| C Kim, G Tang, FL Baehner, D Watson, JP Costantino, S Paik, S Shak, N Wolmark |
| |
| |
|
| Abstract #6039: Poster Presentation |
| The Impact on the Recurrence Score Due to Patient Variation in the Quantitative Expression of Individual Genes or Gene Groups |
| D Watson, G Palmer, J Baker, S Shak |
| |
| |
|
| Abstract #6111: Poster Presentation |
| Relationship Between Proliferation Genes and Expression of Hormone and Growth Factor Receptors: Quantitative RT-PCR in 10,618 Breast Cancers |
| S Shak, FL Baehner, G Palmer, JT Ballard, J Baker, D Watson |
| |
| |
|
| Abstract #6118: Poster Presentation |
| Subtypes of Breast Cancer Defined by Standardized Quantitative RT-PCR Analysis of 10,618 Tumors |
| S Shak, FL Baehner, G Palmer, JT Ballard, J Baker, D Watson |
| |
| |
2006 ASCO Annual Meeting―Atlanta, GA |
| Abstract #538: Poster Discussion |
| Gene Expression Profiles in Formalin-Fixed, Paraffin-Embedded (FFPE) Core Biopsies Predict Docetaxel Chemosensitivity |
| JC Chang, A Makris, SG Hilsenbeck, JR Hackett, J Jeong, ML Liu, J Baker, K Sexton, CK Osborne, S Shak |
| |
| |
|
| Abstract #3518: Poster Discussion |
| Relationship Between Tumor Gene Expression and Recurrence in Stage II/III Colon Cancer: Quantitative RT-PCR Assay of 757 Genes in Fixed Paraffin-Embedded (FPE) Tissue |
| MJ O’Connell, S Paik, G Yothers, JP Costantino, JW Cowens, KM Clark, J Baker, J Hackett, D Watson, N Wolmark |
| |
| |
|
| Abstract #6024: Poster Discussion |
| 21-Gene RT-PCR Assay in Lymph Node-Negative (LN-), Estrogen Receptor-Positive (ER+) Breast Cancer: An Economic Analysis Including Prognostic and Predictive Information |
| LE Cosler, NM Kuderer, J Hornberger, GH Lyman |
| |
| |
2006 AACR Annual Meeting―Washington, DC |
| Abstract #3604: Poster Discussion |
| Multiple GSTM Gene Family Members Are Recurrence Risk Markers in Breast Cancer |
| M Kiefer, K Hoyt, J Hackett, MG Walker, J Baker |
| |
| |
2005 SABCS―San Antonio, TX |
| Abstract #29: Oral Presentation |
| Association Between the 21-Gene Recurrence Score Assay (RS) and Risk of Loco-Regional Failure in Node-Negative, ER-Positive Breast Cancer: Results from NSABP B-14 and NSABP B-20 |
| E Mamounas, G Tang, J Bryant, S Paik, S Shak, JP Costantino, D Watson, DL Wickerham, N Wolmark |
| |
| |
|
| Abstract #310: Poster Discussion |
| Measurement of Gene Expression Using Tissue Microarray Cores of Paraffin-Embedded Breast Cancer Tissue |
| J Baker, J Salter, ML Liu, JR Hackett, M Cronin, S Shak, M Dowsett |
| |
| |
|
| Abstract #2049: Poster Session |
| Impact of Oncotype DX™ on Decision Making in Breast Cancer Clinical Practice |
| R Oratz, D Paul, A Cohn, S Sedlacek |
| |
| |
2005 ASCO Annual Meeting―Orlando, FL |
| Abstract #510: Oral Presentation |
| Expression of the 21 Genes in the Recurrence Score Assay and Tamoxifen Clinical Benefit in the NSABP Study B-14 of Node-Negative, Estrogen Receptor-Positive Breast Cancer |
| S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, D Watson, J Bryant, JP Costantino, N Wolmark |
| |
| |
|
| Abstract #603: Poster Session |
| Gene Expression and Breast Cancer Mortality in Northern California Kaiser Permanente Patients: A Large Population-Based Case Control Study |
| LA Habel, CP Quesenberry, M Jacobs, D Greenberg, L Fehrenbacher, C Alexander, J Baker, D Watson, J Hackett, S Shak |
| |
| |
2004 SABCS―San Antonio, TX |
| Abstract #24: Oral Presentation |
| Expression of the 21 Genes in the Recurrence Score Assay and Prediction of Clinical Benefit from Tamoxifen in NSABP Study B-14 and Chemotherapy in NSABP Study B-20 |
| S Paik, S Shak, G Tang, C Kim, H Joo, J Baker, M Cronin, D Watson, J Bryant, JP Costantino, N Wolmark |
| |
| |
|
| Abstract #104: Poster Discussion |
| Risk Classification of Breast Cancer Patients by the Recurrence Score Assay: Comparison to Guidelines Based on Patient Age, Tumor Size, and Tumor Grade |
| S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, MG Walker, D Watson, J Bryant, N Wolmark |
| |
| |
|
| Abstract #2081: Poster Discussion |
| A 21-Gene RT-PCR Assay in Lymph Node-Negative (LN-), Estrogen Receptor-Positive (ER+) Early-Stage Breast Cancer (ESBC): An Age-Specific Economic Analysis |
| GH Lyman, L Cosler, J Hornberger |
| |
| |
2004 ASCO Annual Meeting―New Orleans, LA |
| Abstract #501: Oral Presentation |
| Gene Expression Profiles of Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Patients with Locally Advanced Breast Cancer |
| L Gianni, M Zambetti, K Clark, J Baker, M Cronin, G Mariani, J Rodriguez, M Carcangiu, D Watson, P Valagussa, S Shak |
| |
| |
|
| Abstract #6036: Poster Session |
| Economic Analysis of Targeting Chemotherapy (CT) Using a 21-Gene RT-PCR Assay in Lymph Node-Negative (LN-), Estrogen Receptor-Positive (ER+) Early-Stage Breast Cancer (ESBC) |
| LE Cosler, J Hornberger, GH Lyman |
| |
| |
2004 USCAP Annual Meeting―Vancouver, British Columbia |
| Abstract #83 |
| Comparison of ER, PR, HER2, and Ki-67 Quantitative Expression in Formalin-Fixed, Paraffin-Embedded Breast Carcinomas by RT-PCR with Protein Expression by Immunohistochemistry |
| P Bitterman, D Watson, M Cronin, JM Mosquera, M Cobleigh, R Baehner, S Shak, J Baker |
| |
| |
|
| Abstract #80 |
| Use of Macrodissection in Multi-Gene RNA Analysis of Fixed Paraffin- Embedded Tumor Tissue |
| R Baehner, B Hiller, CY Kim, C Alexander, ML Liu, M Pho, D Dutta, J Jeong, A Nguyen, M Walker, M Cronin, J Baker, S Paik |
| |
| |
|
| Abstract #1491 |
| Reproducibility of Quantitative Gene Expression Analysis by a New RT-PCR Assay Using Fixed Paraffin-Embedded Tissues: A Molecular Tomographic Scanning Study |
| M Cronin, D Watson, D Dutta, ML Liu, M Pho, R Baehner, J Esteban, J Baker, S Shak |
| |
| |
2003 SABCS―San Antonio, TX |
| Abstract #16: Oral Presentation |
| Multi-Gene RT-PCR Assay for Predicting Recurrence in Node-Negative Breast Cancer Patients ? NSABP Studies B-20 and B-14 |
| S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, MG Walker, DWatson, T Park, W Hiller, ER Fisher, DL Wickerham, J Bryant, N Wolmark |
| |
| |
|
| Abstract #17: Oral Presentation |
| Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy |
| FJ Esteva, AA Sahin, M Cristofanilli, K Coombes, SJ Lee, J Baker, M Cronin, MG Walker, D Watson, S Shak, GN Hortobagyi |
| |
| |
2003 ASCO Annual Meeting―Chicago, IL |
| Abstract #763: Oral Presentation |
| Quantitative Gene Expression in Non-Small Cell Lung Cancer from Paraffin-Embedded Tissue Specimens: Predicting Response to Gefitinib, an EGFR Kinase Inhibitor |
| RB Natale, S Shak, N Aronson, S Averbuch, W Fox, D Luthringer, K Clark, J Baker, M Cronin, DB Agus |
| |
| |
|
| Abstract #3415: Poster Session |
| Tumor Gene Expression Predicts Distant Disease-Free Survival (DDFS) in Breast Cancer Patients with 10 or More Positive Nodes: High Throughput RT-PCR Assay of Paraffin-Embedded Tumor Tissues |
| MA Cobleigh, P Bitterman, J Baker, M Cronin, ML Liu, R Borchik, B Tabesh, J Mosquera, MG Walker, S Shak |
| |
| |
|
| Abstract #3416: Poster Discussion |
| Tumor Gene Expression and Prognosis in Breast Cancer: Multi-Gene RT-PCR Assay of Paraffin-Embedded Tissue |
| JM Esteban, J Baker, M Cronin, ML Liu, MG Llamas, MG Walker, R Mena, S Shak |
| |
| |
|
| Abstract #3466: Poster Session |
| Predicting Response to Neoadjuvant Chemotherapy in Invasive Breast Cancer: Gene Expression Profiling of Paraffin-Embedded Core Biopsy Tissue |
| SE Soule, S Shak, J Baker, M Cronin, ML Liu, S Badve, KD Miller, GW Sledge |
| |
| |
2003 AACR Oncogenomics Meeting―Phoenix, AZ |
| Poster Session |
| Gene Expression Profiling of Fixed, Paraffin-Embedded Tumor Specimens, Using a 192 Gene Panel RT-PCR Assay |
| M Kiefer, J Stephans, ML Liu, D Dutta, M Pho, A Nguyen, J Jeong, M Cronin, JM Esteban |
| |
| |
|
|
| Strategies to Optimize Anti-Receptor Therapies |
| J Baselga |
| |
| |
2002 ASCO Annual Meeting―Orlando, FL |
| Abstract #3017 |
| Gene Expression Profiling of Fixed Paraffin-Embedded Breast Cancer Tissues |
| M Kiefer, J Stephans, S Abulaban, S Shodhan, MC Alexander, JM Esteban |
| |